The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study

Status:	Recruiting
Conditions:	Lymphoma, Lymphoma
Therapuetic Areas:	Oncology
Healthy:	No
Age Range:	18 - Any
Updated:	6/16/2018
Start Date:	July 2015
End Date:	June 2020
Contact:	Julianne Lunde
Email:	lunde.julianne@mayo.edu
Phone:	507-266-2657

The goal of this infrastructure grant is to establish and maintain a cohort of over 12,000
non-Hodgkin lymphoma (NHL) patients to support broad and cutting-edge research that
identifies clinical (including co-morbid diseases), epidemiologic (including lifestyle and
other exposures), host genetic, tumor, and treatment factors, as well as the interaction
among these factors, on short and long-term outcomes. These efforts will identify new
approaches to improve the survival and well-being of NHL patients.

Newly diagnosed non-Hodgkin lymphoma (NHL) patients will be recruited from each center
participating in the LEO cohort. At time of consent, participants will be asked to completed
several questionnaires collecting health history, current medical and quality of life
questions. Patients will also provide a baseline blood sample that will processed locally and
stored centrally for future research use. Additionally, consent is given for use of excess
clinical tumor tissue for research use.

Inclusion Criteria:

- Newly diagnosed non-Hodgkin Lymphoma (NHL), within 183 days of enrollment

- Patients may have been treated as long as initial NHL diagnosis is within 6 months of
enrollment

- 18 years of age or older

Exclusion Criteria:

- Lymphoma diagnosis greater than 184 days from date of consent

We found this trial at

sites

Weill-Cornell Medical College

New York, New York 10021

Principal Investigator: Peter Martin, MD

Phone: 212-746-2190

from

New York, NY